The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Merck Sharp & Dohme; Roche
Clinical outcomes in patients (pts) with previously treated advanced hepatocellular carcinoma (HCC) experiencing hepatitis B virus (HBV) DNA increases during tislelizumab (TIS) treatment in RATIONALE-208.
 
Ann-Lii Cheng
Honoraria - AstraZeneca; Bayer Yakuhin; Eisai; Genentech/Roche
Consulting or Advisory Role - AstraZeneca; Bayer Schering Pharma; BeiGene; Bristol-Myers Squibb; Eisai; Genentech/Roche; Ipsen; IQVIA; MSD; Ono Pharmaceutical; Roche
 
Jinlin Hou
No Relationships to Disclose
 
Weijia Fang
No Relationships to Disclose
 
Zhiwei Li
No Relationships to Disclose
 
Sheng Hu
No Relationships to Disclose
 
Hongming Pan
No Relationships to Disclose
 
Yajin Chen
No Relationships to Disclose
 
Chiun Hsu
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb-Ono Pharmaceutical; Eisai; Ipsen; MSD; Novartis; PharmaEngine; Roche; TTY Biopharm
Research Funding - Bristol-Myers Squibb-Ono Pharmaceutical; Ipsen; Roche
 
Yuxian Bai
No Relationships to Disclose
 
Zhiqiang Meng
No Relationships to Disclose
 
Ming-Mo Hou
No Relationships to Disclose
 
Congying Xie
No Relationships to Disclose
 
Yong Liu
No Relationships to Disclose
 
John Wu
No Relationships to Disclose
 
Bai Li
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Sandra Chica-Duque
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Other Relationship - Turning Point Therapeutics (I)
 
Zhenggang Ren
No Relationships to Disclose